Stocks

Glaukos GKOS

Health care sectorNYSE

What to see in Glaukos now

Is Wall Street adding or cutting?+30

366 13F filers hold it · +30 against the quarter before · shares held +4.9%

Holdings of 06/30
Are insiders selling?−$249.2K

1 insiders, a net sale of $249.2K in 90 days

Filed 09/28
What comes next?10/13 (Tue)

10/13 estimated earnings

Due 10/13

Company

Exchange
NYSE
Industry
Surgical & Medical Instruments & Apparatus
Headquarters
Aliso Viejo, California
Fiscal year end
12/31
Next earnings
10/13, estimated
  • 366 13F filers hold it · +30 against the quarter before · shares held +4.9%Holdings of 06/30

Funds

13F filers: 366 · +30 since the quarter before · 06/30 holdings

Famous funds that held Glaukos in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsGlaukos GKOS · 06/30 holdings$4.2MNo quarter before
Bridgewater AssociatesGlaukos GKOS · 06/30 holdings$462.6KNew position
All tracked funds

5% stakes

Holder
Janus Henderson Group05/159.2%5,348,395 sh+3.9pp
Vanguard Capital Management04/295.07%2,947,047 shFirst report
Vanguard Portfolio Management04/295.6%3,256,962 shFirst report
Janus Henderson Group02/175.3%3,018,787 shFirst report
Primecap Management02/115.88%3,376,928 shFirst report
Wellington Management Group02/100.8%486,824 sh−4.9pp
Wellington Management Group25/08/125.7%3,244,404 shFirst report
FMR25/08/074.5%2,561,428.45 sh−6.5pp
All 5% stake reports on Glaukos

26-week trading

No member of Congress reported a trade in Glaukos GKOS in the past 90 days. Insiders filed 0 purchases and 4 sales on the open market over the same period, a net sale of $249.2K.

Common questions

Did Glaukos GKOS insiders buy or sell in the past 90 days?
In the past 90 days insiders filed 0 purchases and 4 sales on the open market. Sales came to $249.2K.